These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 22643331)

  • 1. Inhibitory effect of tacrolimus on p38 mitogen-activated protein kinase signaling in kidney transplant recipients measured by whole-blood phosphospecific flow cytometry.
    Vafadari R; Hesselink DA; Cadogan MM; Weimar W; Baan CC
    Transplantation; 2012 Jun; 93(12):1245-51. PubMed ID: 22643331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conversion to Once-Daily Tacrolimus Results in Increased p38MAPK Phosphorylation in T Lymphocytes of Kidney Transplant Recipients.
    Kannegieter NM; Shuker N; Vafadari R; Weimar W; Hesselink DA; Baan CC
    Ther Drug Monit; 2016 Apr; 38(2):280-4. PubMed ID: 26606072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamic Monitoring of Tacrolimus-Based Immunosuppression in CD14+ Monocytes After Kidney Transplantation.
    Kannegieter NM; Hesselink DA; Dieterich M; de Graav GN; Kraaijeveld R; Rowshani AT; Leenen PJM; Baan CC
    Ther Drug Monit; 2017 Oct; 39(5):463-471. PubMed ID: 28640063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative analysis of regulatory T cells in kidney graft recipients: a relationship with calcineurin inhibitor level.
    Calvo-Turrubiartes M; Romano-Moreno S; García-Hernández M; Chevaile-Ramos JA; Layseca-Espinosa E; González-Amaro R; Portales-Pérez D
    Transpl Immunol; 2009 May; 21(1):43-9. PubMed ID: 19233271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between everolimus and tacrolimus in renal transplant recipients: a pharmacokinetic controlled trial.
    Pascual J; del Castillo D; Cabello M; Pallardó L; Grinyó JM; Fernández AM; Brunet M
    Transplantation; 2010 Apr; 89(8):994-1000. PubMed ID: 20335831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential T Cell Signaling Pathway Activation by Tacrolimus and Belatacept after Kidney Transplantation: Post Hoc Analysis of a Randomised-Controlled Trial.
    Kannegieter NM; Hesselink DA; Dieterich M; de Graav GN; Kraaijeveld R; Baan CC
    Sci Rep; 2017 Nov; 7(1):15135. PubMed ID: 29123208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NK026680 inhibits T-cell function in an IL-2-dependent manner and prolongs cardiac allograft survival in rats.
    Shibasaki S; Yamashita K; Goto R; Oura T; Wakayama K; Hirokata G; Shibata T; Igarashi R; Haga S; Ozaki M; Todo S
    Transpl Immunol; 2012 Jan; 26(1):42-9. PubMed ID: 22019622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow cytometric analysis of phospho-p38 mitogen-activated kinase (MAPK): p38 MAPK does not mediate the effect of adalimumab on peripheral T cell cytokine production in rheumatoid arthritis.
    Aerts NE; Ebo DG; Bridts CH; Stevens WJ; De Clerck LS
    Cytokine; 2009 Sep; 47(3):178-84. PubMed ID: 19616965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-specific activation profile of extracellular signal-regulated kinase 1/2, Jun N-terminal kinase, and p38 mitogen-activated protein kinases in asthmatic airways.
    Liu W; Liang Q; Balzar S; Wenzel S; Gorska M; Alam R
    J Allergy Clin Immunol; 2008 Apr; 121(4):893-902.e2. PubMed ID: 18395552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow cytometry-based pharmacodynamic monitoring after organ transplantation.
    Dieterlen MT; Eberhardt K; Tarnok A; Bittner HB; Barten MJ
    Methods Cell Biol; 2011; 103():267-84. PubMed ID: 21722807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A switch from conventional twice-daily tacrolimus to once-daily extended-release tacrolimus in stable kidney transplant recipients.
    Hatakeyama S; Fujita T; Yoneyama T; Yoneyama T; Koie T; Hashimoto Y; Saitoh H; Funyu T; Narumi S; Ohyama C
    Transplant Proc; 2012 Jan; 44(1):121-3. PubMed ID: 22310594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Halofuginone inhibits NF-kappaB and p38 MAPK in activated T cells.
    Leiba M; Cahalon L; Shimoni A; Lider O; Zanin-Zhorov A; Hecht I; Sela U; Vlodavsky I; Nagler A
    J Leukoc Biol; 2006 Aug; 80(2):399-406. PubMed ID: 16769768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble FGL2 induced by tumor necrosis factor-α and interferon-γ in CD4+ T cells through MAPK pathway in human renal allograft acute rejection.
    Zhao Z; Wang L; Yang C; Zhao T; Li L; Hu L; Wu D; Rong R; Xu M; Zhu T
    J Surg Res; 2013 Oct; 184(2):1114-22. PubMed ID: 23664593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological monitoring of calcineurin inhibitors for predicting cytomegalovirus infection in kidney transplant recipients.
    Couzi L; Thiébaut R; Carron JC; Moreau JF; Merville P; Taupin JL
    Transplantation; 2008 Oct; 86(8):1060-7. PubMed ID: 18946343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential requirements for ERK1/2 and P38 MAPK activation by thrombin in T cells. Role of P59Fyn and PKCepsilon.
    Maulon L; Mari B; Bertolotto C; Ricci JE; Luciano F; Belhacene N; Deckert M; Baier G; Auberger P
    Oncogene; 2001 Apr; 20(16):1964-72. PubMed ID: 11360180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced CD40L expression on ex vivo activated CD4+ T-lymphocytes from patients with excellent renal allograft function measured with a rapid whole blood flow cytometry procedure.
    Lederer SR; Friedrich N; Gruber R; Landgraf R; Toepfer M; Sitter T
    Int Arch Allergy Immunol; 2004 Mar; 133(3):276-84. PubMed ID: 14976397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring the Intracellular Tacrolimus Concentration in Kidney Transplant Recipients with Stable Graft Function.
    Han SS; Yang SH; Kim MC; Cho JY; Min SI; Lee JP; Kim DK; Ha J; Kim YS
    PLoS One; 2016; 11(4):e0153491. PubMed ID: 27082871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell activation signals up-regulate p38 mitogen-activated protein kinase activity and induce TNF-alpha production in a manner distinct from LPS activation of monocytes.
    Schafer PH; Wang L; Wadsworth SA; Davis JE; Siekierka JJ
    J Immunol; 1999 Jan; 162(2):659-68. PubMed ID: 9916683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tacrolimus trough levels and level-to-dose ratio in stable renal transplant patients converted to a once-daily regimen.
    Meçule A; Tinti F; Poli L; Bachetoni A; Umbro I; Nofroni I; Lai Q; Pretagostini R; Berloco PB; Mitterhofer AP
    Transplant Proc; 2011 May; 43(4):1024-7. PubMed ID: 21620042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The autoimmune suppressor Gadd45alpha inhibits the T cell alternative p38 activation pathway.
    Salvador JM; Mittelstadt PR; Belova GI; Fornace AJ; Ashwell JD
    Nat Immunol; 2005 Apr; 6(4):396-402. PubMed ID: 15735649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.